Next, gene fusion analysis was performed on RNA from FFPE tissue from 169 lung cancers in the prospective 533-sample cohort, which did not harbor mutations in EGFR, KRAS or BRAF (referred to as triple-negative cases hereon) (Figure 1). This evidence concerns the gene BRAF and lung cancer.